Doctor profile · Federal record

Dr. Jeffrey Ashley, MD

Dermatology Physician (CMS: Dermatology) · Burbank, CA

  • NPI 1639155880
  • Accepts Medicare
  • MIPS 79.6 / 100 · 2023
  • 52 yrs in practice
  • Male
  • Solo practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
2720 W Magnolia Blvd
Burbank, CA 915053034
(818) 842-8000
fax (323) 935-8804
Mailing address
2625 W Alameda Ave, Suite 517
Burbank, CA 915054806

Credentials & registration

NPPES · NUCC
NPI registered
December 2005 — 21 yrs on file
Profile last updated
December 31, 2019
Year of graduation
1974 — 52 yrs since
Specialty taxonomy
207N00000X — NUCC code
State license (1)
California #G30335
Medicaid
CA #OG303350

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1639155880. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
4,345
Distinct HCPCS
10
Medicare allowed
$337,382
HCPCS Description Services Patients Avg allowed
99213 Established patient office or other outpatient visit, 20-29 minutes 1,351 788 $98
17003 Destruction of precancer skin growth, 2-14 growths 940 209 $8
17000 Destruction of precancer skin growth, 1 growth 435 321 $57
17110 Destruction of skin growth, 1-14 growths 401 312 $130
11102 Biopsy of related skin growth, first growth 331 283 $103
99212 Established patient office or other outpatient visit, 10-19 minutes 172 144 $62
88305 Pathology examination of tissue using a microscope, intermediate complexity 171 136 $80
99203 New patient office or other outpatient visit, 30-44 minutes 160 160 $122
99214 Established patient office or other outpatient visit, 30-39 minutes 100 64 $139
11103 Biopsy of related skin growth, each additional growth 67 55 $57

In context: peer comparison

Among 6 peers in this city , average services per provider: 140. This provider delivers 31× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$2,754
Transactions
126
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Incyte Corporation 18 $386.94
GENZYME CORPORATION 8 $360.56
Regeneron Healthcare Solutions, Inc. 11 $352.19
Ortho Dermatologics, a division of Bausch Health US, LLC 22 $293.25
ABBVIE INC. 16 $292.17
SUN PHARMACEUTICAL INDUSTRIES INC. 11 $207.28
Dermavant Sciences, Inc. 9 $168.32
UCB, Inc. 5 $123.68
Arcutis Biotherapeutics, Inc. 6 $110.64
MAYNE PHARMA COMMERCIAL LLC 7 $85.84
PFIZER INC. 2 $85.57
LEO Pharma Inc. 3 $72.44
Amgen Inc. 3 $67.72
E.R. Squibb & Sons, L.L.C. 2 $58.53
Galderma Laboratories, L.P. 3 $48.80

By nature of payment

Food and Beverage
$2,754

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
947
Patients
536
Total drug cost
$36,285
Drug Type Claims Patients Total cost
Ketoconazole Generic 257 109 $4,957
Ciclopirox (Ciclopirox Olamine) Brand 136 78 $4,438
Betamethasone Diprop Augmented (Betamethasone/Propylene Glyc) Brand 98 65 $2,015
Imiquimod Generic 70 53 $3,413
Doxycycline Hyclate Generic 64 26 $2,088
Mometasone Furoate Generic 57 42 $1,109
Triamcinolone Acetonide Generic 55 32 $456
Fluorouracil Generic 49 33 $5,665
Mupirocin Generic 43 39 $365
Calcipotriene Generic 33 18 $4,585

Frequently asked questions

Auto-generated from federal data
What is Dr. Jeffrey Ashley's medical specialty?
Dr. Jeffrey Ashley practices Dermatology Physician in Burbank, CA.
Where does Dr. Jeffrey Ashley practice?
Dr. Jeffrey Ashley practices at 2720 W Magnolia Blvd, Burbank, CA 915053034. Office phone: 8188428000.
What is Dr. Jeffrey Ashley's NPI?
Dr. Jeffrey Ashley's National Provider Identifier (NPI) is 1639155880, issued by NPPES.
Does Dr. Jeffrey Ashley accept Medicare assignment?
Yes. Dr. Jeffrey Ashley accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Jeffrey Ashley commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.